• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, August 20, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

How Chlamydia gain access to human cells

Bioengineer by Bioengineer
October 30, 2019
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Publication in Nature Communications

IMAGE

Credit: HHU / Jan Galle


Chlamydia are bacteria that can infect human and animal cells. Human health is particularly affected by Chlamydia pneumoniae (Cpn) and Chlamydia trachomatis. Chlamydia pneumoniae attacks the upper and lower respiratory tract and causes bronchitis, sinusitis and chest infections. Importantly, infections with this bacterium are associated with many chronic diseases such as chronic bronchitis, asthma, atherosclerosis and Alzheimer’s disease.

Chlamydia multiply only inside of human cells. To do so, they first have to bind to the host cell from the outside and then enter the cell in a second step. Understanding these two mechanisms is one of the key research areas at the Institute of Functional Genome Research of Microorganisms headed up by Prof. Dr. Johannes Hegemann.

Each cell is surrounded by a membrane known as the ‘plasma membrane’. This membrane comprises lots of individual molecules called ‘phospholipids’. There are also membrane proteins, which are responsible for transporting materials between the cell interior and the outer environment as well as for intercellular communication. One component of the membrane is the phospholipid phosphatidylserine, or ‘PS’ for short. In healthy cells, it is located on the inner membrane leaflet, but if the cell is diseased, it is transported to the external membrane leaflet. Here, PS serves as a marker for programmed cell death (apoptosis).

In the working group of Prof. Hegemann, a protein called LIPP was discovered in Cpn that plays a key role in the binding of the bacterium to a human cell. This protein is located on the surface of the bacterium. In earlier studies, the researchers in Düsseldorf found that a chlamydial infection with Cpn is increased substantially if LIPP is added artificially.

This finding was the start of the present study.

One of their findings was that the LIPP protein binds directly to the plasma membrane and traverses the membrane after binding. Several LIPP molecules then form a pore in the plasma membrane.

Next, however, the bound LIPP transports the PS molecule, normally located on the inner membrane leaflet, to the outside. LIPP was the first protein to be identified that transports a component of the inner membrane leaflet to the surface of the cell when added externally. Surprisingly, this does not trigger cell death. Instead, the cell remains viable. This applies both to cells confronted only with the LIPP proteins and to those also infected with Chlamydia.

The research team proposes that it is beneficial for the Chlamydium to transport the PS molecule of the host cell outward using its LIPP protein. Possibly, at the place where the PS with the LIPP protein is located on the membrane, the membrane is so deformed that the Chlamydium can enter the cell more easily. It is also possible that the PS molecules transported to the outer membrane leaflet of the human cell serve as a receptor for the bacterium.

Dr. Jan Galle, first author of the study, had this to say about the prospects arising from these findings: “The LIPP protein has now become a possible target to prevent a chlamydial infection. If we succeed in coming up with a drug that restricts the function of the LIPP protein, it may be possible to prevent the infection.” Likewise it is now possible to examine whether other pathogens have a tool similar to Chlamydia that they use to enter human cells. “If this were the case, it could form the basis for an extensive strategy against pathogenic bacteria,” emphasises Prof. Hegemann.

###

Funding by the Jürgen Manchot Foundation and the SFB 1208

The LIPP protein was discovered as part of the research carried out in the “MOI – Molecules of Infection” Graduate School funded by the Jürgen Manchot Foundation and was further characterised within the framework of a Manchot PhD scholarship. This resulted in the sub-project A5 in the DFG-funded special research area 1208 “Identity and Dynamics of Membrane Systems” at HHU, where the key discoveries around the LIPP function were then made.

Original publication

Galle JN, Fechtner T, Eierhoff T, Römer W, Hegemann JH, A Chlamydia pneumoniae adhesin induces phosphatidylserine exposure on host cells, Nature Communications 2019 Oct 11;10(1):4644

DOI: 10.1038/s41467-019-12419-8

Media Contact
Dr. Arne Claussen
[email protected]
49-021-181-10896

Related Journal Article

http://dx.doi.org/10.1038/s41467-019-12419-8

Tags: BacteriologyBiologyCell BiologyInfectious/Emerging DiseasesMedicine/HealthMicrobiology
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

August 20, 2025
Electrochemical Loading Boosts Deuterium Fusion

Electrochemical Loading Boosts Deuterium Fusion

August 20, 2025

Oral Dextrose Gel Boosts Neonatal Hypoglycemia Treatment

August 20, 2025

Multi-Ancestry Study Reveals New Keloid Genes

August 20, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    141 shares
    Share 56 Tweet 35
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    80 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    60 shares
    Share 24 Tweet 15
  • Predicting Colorectal Cancer Using Lifestyle Factors

    47 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Why Mental Health Guidance Can Increase Your To-Do List

Pilot Study Unveils How Music Therapy Eases Pain Following Pancreatic Surgery

UCLA and UC Santa Barbara’s BioPACIFIC MIP Secures Renewed NSF Funding to Propel AI-Driven Biobased Materials Innovation

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.